137 related articles for article (PubMed ID: 34260103)
1. Tinea pseudoimbricata: observations from a clinicoepidemiological and mycological study from eastern India.
Das A; Sil A; Verma SB; Kumar S
Clin Exp Dermatol; 2022 Jan; 47(1):147-149. PubMed ID: 34260103
[TBL] [Abstract][Full Text] [Related]
2. Male genital dermatophytosis - clinical features and the effects of the misuse of topical steroids and steroid combinations - an alarming problem in India.
Verma SB; Vasani R
Mycoses; 2016 Oct; 59(10):606-14. PubMed ID: 27028087
[TBL] [Abstract][Full Text] [Related]
3. Antifungal therapeutic failures in India: an important issue being overlooked.
Sonthalia S; Agrawal M; Goldust M; Das S; Bhattacharya SN
Lancet Infect Dis; 2018 Nov; 18(11):1181-1182. PubMed ID: 30507401
[No Abstract] [Full Text] [Related]
4. Disseminated tinea incognita in a patient with ichthyosis vulgaris and eczema.
Steele L; Hong A; Balogh P; O'Toole EA; Harwood CA; Maruthappu T
Clin Exp Dermatol; 2021 Jan; 46(1):210-212. PubMed ID: 32845026
[No Abstract] [Full Text] [Related]
5. Patient practices regarding topical drugs and a 'nudge' to prevent topical steroid abuse.
Barve A; Petkar S; Farande P; Patel J; Raval A
Clin Exp Dermatol; 2021 Apr; 46(3):575-577. PubMed ID: 33131125
[No Abstract] [Full Text] [Related]
6. Childhood tinea incognito caused by Trichophyton mentagrophytes var. interdigitale mimicking pustular psoriasis.
Kawakami Y; Oyama N; Sakai E; Nishiyama K; Suzutani T; Yamamoto T
Pediatr Dermatol; 2011; 28(6):738-739. PubMed ID: 21418291
[TBL] [Abstract][Full Text] [Related]
7. Topical antifungal-corticosteroid fixed-drug combinations: Need for urgent action.
Rana P; Ghadlinge M; Roy V
Indian J Pharmacol; 2021; 53(1):82-84. PubMed ID: 33976006
[No Abstract] [Full Text] [Related]
8. Tinea incognito in an urban pediatric population.
Stringer T; Gittler JK; Orlow SJ
Cutis; 2018 Nov; 102(5):370-372. PubMed ID: 30566538
[TBL] [Abstract][Full Text] [Related]
9. Clinical, epidemiological, and therapeutic profile of dermatophytosis.
Pires CA; Cruz NF; Lobato AM; Sousa PO; Carneiro FR; Mendes AM
An Bras Dermatol; 2014; 89(2):259-64. PubMed ID: 24770502
[TBL] [Abstract][Full Text] [Related]
10. Topical therapy for dermatophytoses: should corticosteroids be included?
Erbagci Z
Am J Clin Dermatol; 2004; 5(6):375-84. PubMed ID: 15663334
[TBL] [Abstract][Full Text] [Related]
11. Tinea faciei in a central Portuguese hospital: A 9-year survey.
Borges A; Brasileiro A; Galhardas C; Apetato M
Mycoses; 2018 Apr; 61(4):283-285. PubMed ID: 29285801
[TBL] [Abstract][Full Text] [Related]
12. Topical steroid-induced tinea pseudoimbricata: a striking form of tinea incognito.
Verma S; Hay RJ
Int J Dermatol; 2015; 54(5):e192-3. PubMed ID: 25601089
[No Abstract] [Full Text] [Related]
13. Risk factors for chronic and chronic-relapsing tinea corporis, tinea cruris and tinea faciei: Results of a case-control study.
Singh S; Verma P; Chandra U; Tiwary NK
Indian J Dermatol Venereol Leprol; 2019; 85(2):197-200. PubMed ID: 30719987
[No Abstract] [Full Text] [Related]
14. The economic burden of topical corticosteroid use in dermatophytosis: a cost-of-illness analysis of steroid-modified vs. steroid-naive dermatophytosis.
Jagadeesan S; Sreekumar S; Sajini L; Binu A; Das A
Clin Exp Dermatol; 2023 Jul; 48(8):909-912. PubMed ID: 37040440
[TBL] [Abstract][Full Text] [Related]
15. Medication Practice of Patients with Dermatophytosis.
Poudyal Y; Joshi SD
JNMA J Nepal Med Assoc; 2016; 55(203):7-10. PubMed ID: 27935915
[TBL] [Abstract][Full Text] [Related]
16. Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India).
Rajagopalan M; Inamadar A; Mittal A; Miskeen AK; Srinivas CR; Sardana K; Godse K; Patel K; Rengasamy M; Rudramurthy S; Dogra S
BMC Dermatol; 2018 Jul; 18(1):6. PubMed ID: 30041646
[TBL] [Abstract][Full Text] [Related]
17. New Antifungal Agents and New Formulations Against Dermatophytes.
Gupta AK; Foley KA; Versteeg SG
Mycopathologia; 2017 Feb; 182(1-2):127-141. PubMed ID: 27502503
[TBL] [Abstract][Full Text] [Related]
18. Tinea of vellus hair: an indication for systemic antifungal therapy.
Gómez-Moyano E; Crespo-Erchiga V
Br J Dermatol; 2010 Sep; 163(3):603-6. PubMed ID: 20408835
[TBL] [Abstract][Full Text] [Related]
19. A clinicoepidemiological study on tinea incognita with assessment of its treatment strategies and drug prescribing practices in a tertiary care hospital.
Balasubramanian A; Gopalan K; Akbar Ali NA; Vadhooth R; Jabbar MSA; Ramalingam K
Mycoses; 2023 Sep; 66(9):825-839. PubMed ID: 37277323
[TBL] [Abstract][Full Text] [Related]
20. Isoconazole nitrate vs isoconazole nitrate and diflucortolone valerate in the treatment of tinea inguinalis: results of a multicenter retrospective study.
Veraldi S; Persico MC; Schianchi R
J Drugs Dermatol; 2012 Nov; 11(11):e70-3. PubMed ID: 23135097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
